United States · 
Who invested in Theravance?
Theravance's investors include GlaxoSmithKline.
United States · Growth startup
Who invested in Theravance
One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$129Mraised across 1 round since 2010, from 1 source
- Latest round
- Growth, $129MNov 2010
- Investors
- 1
The rounds
- Nov 2010
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Theravance
How much has Theravance raised?
Theravance has raised $129M across 1 round since 2010.
When did Theravance last raise?
Theravance's most recent round was a Growth of $129M in Nov 2010.
What was Theravance's biggest round?
Its most recent round, $129M in Nov 2010, is also its largest on record.
Who backed Theravance first?
Theravance's first round on record, in Nov 2010, was backed by GlaxoSmithKline.
What stage is Theravance at?
Theravance's latest named round is a Growth, in Nov 2010.
Where is Theravance based?
Theravance is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.